Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Non-Current Assets (2020 - 2025)

Agilon Health (AGL) has disclosed Other Non-Current Assets for 5 consecutive years, with $151.1 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Assets rose 4.01% year-over-year to $151.1 million, compared with a TTM value of $151.1 million through Dec 2024, up 4.01%, and an annual FY2024 reading of $151.1 million, up 4.01% over the prior year.
  • Other Non-Current Assets was $151.1 million for Q4 2024 at Agilon Health, up from $145.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $151.1 million in Q4 2024 and bottomed at $43.7 million in Q4 2020.
  • Average Other Non-Current Assets over 5 years is $112.3 million, with a median of $117.1 million recorded in 2021.
  • The sharpest move saw Other Non-Current Assets surged 158.49% in 2021, then fell 7.95% in 2022.
  • Year by year, Other Non-Current Assets stood at $43.7 million in 2020, then skyrocketed by 158.49% to $113.0 million in 2021, then rose by 3.51% to $116.9 million in 2022, then increased by 24.28% to $145.3 million in 2023, then increased by 4.01% to $151.1 million in 2024.
  • Business Quant data shows Other Non-Current Assets for AGL at $151.1 million in Q4 2024, $145.3 million in Q4 2023, and $127.3 million in Q2 2023.